LITS
LITS
NASDAQ · Biotechnology

Lite Strategy Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.94
+0.01 (+1.29%)
As of Aug 8, 2:23 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +3,943.6% upside
Low Target $26.78
Average Target $38.05
High Target $46.02
Current Price $0.94
Current
$0.94
Target
$38.05
$26.78 $38.05 avg $46.02
Scenario Analysis
Bear Case
$26.78
2,745.9%
Low target
Base Case
$38.05
+3,943.6%
Avg target
Bull Case
$46.02
+4,790.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$5.55
-83.0% from high
52-Week Low
$0.69
+36.6% from low
Target vs 52W High
$38.05
+585.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%